Previous 10 | Next 10 |
Seventeen subjects with advanced cancer pain received epidural RTX (0.4 to 25 mcg). No dose limiting toxicities were reported, and a majority of patients reported meaningful pain reduction of 30% or more vs. baseline.Sorrento (SRNE) expects to immediately submit to the FDA a request to procee...
Seventeen subjects with advanced cancer pain received epidural RTX (0.4 to 25 mcg). No dose limiting toxicities were reported. A majority of patients reported meaningful pain reduction of 30% or more from baseline. Sorrento expects to submit to the FDA a request to proceed w...
Should You Look For Penny Stocks To Buy Or Is Amazon Better? Penny stocks are inherently volatile, that's a given. However, what we're seeing in the stock market today is that everything is volatile. It doesn't matter if you're looking at the S&P 500 ETF ( SPY ) or Amazon Inc. ( AMZN ), ...
Gainers: Ebang International (NASDAQ: EBON ) +42% . More news on: Ebang International Holdings Inc., Cardiff Oncology, Inc., Herman Miller, Inc., Stocks on the move, , Read more ...
Should You Look For Penny Stocks To Buy Or Is Amazon Better? Penny stocks are inherently volatile, that’s a given. However, what we’re seeing in the stock market today is that everything is volatile. It doesn’t matter if you’re looking at the S&P ETF ( SPY ETF...
Shares of the mid-cap biopharma Sorrento Therapeutics (NASDAQ: SRNE) jumped by as much as 35% in pre-market trading Thursday morning. The stock is heating up today in response to the Food and Drug Administration clearing Sorrento's COVID-19 neutralizing antibody, COVI-Guard (STI-1499), for a...
Sorrento Therapeutics (NASDAQ: SRNE ) +30% on FDA nod for early-stage COVID-19 antibody trial. More news on: Sorrento Therapeutics, Inc., Hepion Pharmaceuticals, Inc., Vaccinex, Inc., , Stocks on the move, Read more ...
Sorrento Therapeutics (NASDAQ: SRNE ) receives FDA clearance to with its Phase 1 clinical trial for COVI-GUARD (STI-1499) in hospitalized COVID-19 patients. More news on: Sorrento Therapeutics, Inc., Read more ...
Phase 1 clinical trial for STI-1499 (COVI-GUARD™) in hospitalized COVID-19 patients has received FDA notice that it may proceed with patient enrollment. The initial trial is expected to enroll rapidly and is expected to be followed by large trials targeting a potential Emergency Us...
Looking For Top Biotech Stocks To Watch This Week? Investors seeking out high growth in their investments will often turn to biotech stocks . The boom in the biotechnology industry in recent decades built on the increasing understanding we have on biology. For this reason, investors have been...
News, Short Squeeze, Breakout and More Instantly...
Sorrento Therapeutics Inc. Company Name:
SRNE Stock Symbol:
NASDAQ Market:
Sorrento Therapeutics Inc. Website:
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...
Smart Share Global Limited (EM) is expected to report for Q1 2024 American Rebel Holdings Inc. (AREB) is expected to report for Q1 2024 First Republic Bank (San Francisco, California) (FRCB) is expected to report for Q1 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ...